SARS-CoV-2 evolution during treatment of chronic infection

Carla M. S. Ribeiro; Jane Rowlands; Valentina Ruffolo; Hugo Tordesillas; Ben Bullman; Benjamin J. Dunmore; Stuart Fawke; Stefan Ting Graf; Josh Hodgson; Christopher Huang; Kelvin Hunter; Emma Jones; Ekaterina Legchenko; Cecilia Matara; Jennifer Martin; Federica Mescia; Ciara O’Donnell; Linda Pointon; Nicole Pond; Joy Shih; Rachel Sutcliffe; Tobias Tilly; Carmen Treacy; Zhen Tong; Jennifer Wood; Marta Wylot; Laura Bergamaschi; Ariana Betancourt; Georgie Bower; Chiara Cossetti; Aloka De; Madeline Epping; Stuart Fawke; Nick Gleadall; Richard Grenfell; Andrew Hinch; Oisín Huhn; Sarah Jackson; Isobel Jarvis; D. J. Lewis; Joe Marsden; Francesca Nice; Georgina Okecha; Ommar Omarjee; Marianne Perera; Nathan Richoz; Veronika Romashova; Natalia Savinykh Yarkoni; Rahul Sharma; Luca Stefanucci; Jonathan Stephens; Mateusz Strezlecki; Lori Turner; Eckart M. D. D. De Bie; Katherine Bunclark; Maša Josipović; Michael Mackay; Sabrina Rossi; Steven A. Kemp; Dami A. Collier; Rawlings Datir; Isabella A.T.M. Ferreira; Salma Gayed; Aminu S. Jahun; Myra Hosmillo; Chloe Rees-Spear; Petra Mlčochová; Ines Ushiro Lumb; David J. Roberts; Anita Chandra; Nigel Temperton; Stephen Baker; Gordon Dougan; Christoph Hess; Nathalie Kingston; Paul J. Lehner; Paul Lyons; Nicholas J. Matheson; Willem H. Owehand; Caroline Saunders; Charlotte Summers; James Thaventhiran; Mark Toshner; Michael P. Weekes; Ashlea Bucke; Jo Calder; Laura Canna; Jason Domingo; Anne Elmer; Stewart Fuller; Julie Harris; Sarah Hewitt; Jane Kennet; Sherly Jose; Jenny Kourampa; Anne Meadows; Criona O’Brien; Jane Price; Cherry Publico; Rebecca Rastall

doi:10.1038/s41586-021-03291-y

Keywords

InfectivityVirologyVirusAntibodyMutantPopulationMutationBiologyViral loadNeutralizing antibodyWild typeGeneImmunologyMedicineGenetics

Affiliated Institutions

Related Publications

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge

Mimi Guebre‐Xabier , Nita Patel , Jing-Hui Tian +10 more

There is an urgent need for a safe and protective vaccine to control the global spread of SARS-CoV-2 and prevent COVID-19. Here, we report the immunogenicity and protective effi...

2020 Vaccine 238 citations

IgA dominates the early neutralizing antibody response to SARS-CoV-2

Delphine Sterlin , Alexis Mathian , Makoto Miyara +24 more

Early specific antibody responses against SARS-CoV-2 include IgG, IgM, and IgA, but IgA may neutralize virus and control infection to a larger extent.

2020 Science Translational Medicine 1089 citations

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

Kizzmekia S. Corbett , Darin K. Edwards , Sarah R. Leist +59 more

A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have ...

2020 Nature 1567 citations

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen , Ajay Nirula , Barry N. Heller +19 more

In this interim analysis of a phase 2 trial, one of three doses of neutralizing antibody LY-CoV555 appeared to accelerate the natural decline in viral load over time, whereas th...

2020 New England Journal of Medicine 1412 citations

Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection

Mohamed Elamin Farah , Malak Almasri , Doreen Muth +14 more

Abstract Background. The Middle East respiratory syndrome (MERS) coronavirus causes isolated cases and outbreaks of severe respiratory disease. Essential features of the natural...

2015 Clinical Infectious Diseases 387 citations

Publication Info

Year: 2021
Type: article
Volume: 592
Issue: 7853
Pages: 277-282
Citations: 1053
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

SARS-CoV-2 evolution during treatment of chronic infection

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1053

OpenAlex

Cite This

APA Style

                            
                                
                                    Carla M. S. Ribeiro, 
                                
                                    Jane Rowlands, 
                                
                                    Valentina Ruffolo
                                
                                et al.
                            
                            (2021). 
                            SARS-CoV-2 evolution during treatment of chronic infection. 
                            Nature
                            , 592
                            (7853)
                            , 277-282.
                            https://doi.org/10.1038/s41586-021-03291-y
                        

Identifiers

DOI: 10.1038/s41586-021-03291-y